SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-17-004532
Filing Date
2017-05-03
Accepted
2017-05-03 08:51:05
Documents
2
Period of Report
2017-05-03

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k050317_therapixbio.htm 6-K 18314
2 PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON APRIL 5, 2017, ANNOUNCING T f6k050317ex99i_therapixbio.htm EX-99.1 8699
  Complete submission text file 0001213900-17-004532.txt   28014
Mailing Address 5 AZRIELI CENTER (SQUARE TOWER) TEL-AVIV L3 6702501
Business Address 5 AZRIELI CENTER (SQUARE TOWER) TEL-AVIV L3 6702501 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 17807302
SIC: 2834 Pharmaceutical Preparations